Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 16,086 | 55 | 0 | 0 | 0 |
| Gross Profit | 16,086 | 55 | N/A | N/A | N/A |
| Operating Expenses | 3,302 | 3,589 | 2,990 | 3,115 | 4,802 |
| Operating Income | 12,784 | -3,534 | -2,990 | -3,115 | -4,802 |
| Interest Expense | 32 | 45 | 57 | 69 | 81 |
| Other Income | -128 | 497 | -3,761 | -184 | 372 |
| Pre-tax Income | 12,624 | -3,081 | -6,809 | -3,368 | -4,511 |
| Net Income Continuous | 12,624 | -3,081 | -6,809 | -3,368 | -4,512 |
| Net Income | $12,624 | $-3,081 | $-6,809 | $-3,368 | $-4,512 |
| EPS Basic Total Ops | 2.38 | -0.51 | -1.36 | -0.68 | -0.68 |
| EPS Basic Continuous Ops | 2.48 | -0.59 | -1.31 | -0.70 | -0.72 |
| EPS Diluted Total Ops | 2.55 | -0.68 | -1.36 | -0.68 | -0.68 |
| EPS Diluted Continuous Ops | 2.47 | -0.59 | -1.30 | -0.70 | -0.72 |
| EBITDA(a) | $12,941 | $-3,379 | $-2,852 | $-3,049 | $-4,797 |